PHARMACY software provider, Corum Group's efforts to regain market share have been hampered by the pressure COVID-19 is putting on individual stores, the company reported to investors this morning.
Outlining its performance in the first half of the 2022 financial year in a statement to the Australian Securities Exchange this morning the company reported a 4% bump in revenue - falling short of its target of 15%.
However, the company said its strategy to regain market share remained unchanged.
With 90% of pharmacies not affiliated with the group or banner, Corum plans to target brands through its relationships and head office product, while building on its PharmX platform.
The above article was sent to subscribers in Pharmacy Daily's issue from 10 Feb 22
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 10 Feb 22
